SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-24-000052
Filing Date
2024-03-28
Accepted
2024-03-28 16:35:02
Documents
16
Period of Report
2024-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20240328.htm   iXBRL 8-K 28976
2 EX-99.1 cntapr-q42023.htm EX-99.1 89585
7 GRAPHIC letterheada.jpg GRAPHIC 60436
  Complete submission text file 0001847903-24-000052.txt   394308

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20240328.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20240328_def.xml EX-101.DEF 16868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20240328_lab.xml EX-101.LAB 30840
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20240328_pre.xml EX-101.PRE 18275
19 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20240328_htm.xml XML 4497
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 24799714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)